Literature DB >> 18999351

Deficits in complex motor functions, despite no evidence of procedural learning deficits, among HIV+ individuals with history of substance dependence.

Raul Gonzalez1, Joanna Jacobus, Anup K Amatya, Phillip J Quartana, Jasmin Vassileva, Eileen M Martin.   

Abstract

Human immunodeficiency virus (HIV) and drugs of abuse affect common neural systems underlying procedural memory, including the striatum. The authors compared performance of 48 HIV seropositive (HIV+) and 48 HIV seronegative (HIV-) participants with history of cocaine and/or heroin dependence across multiple Trial Blocks of three procedural learning (PL) tasks: Rotary Pursuit (RP), Mirror Star Tracing (MST), and Weather Prediction (WP). Groups were well matched on demographic, psychiatric, and substance use parameters, and all participants were verified abstinent from drugs. Mixed model analyses of variance revealed that the individuals in the HIV+ group performed more poorly across all tasks, with a significant main effect of HIV serostatus observed on the Mirror Star Tracing and a trend toward significance obtained for the Rotary Pursuit task. No significant differences were observed on the Weather Prediction task. Both groups demonstrated significant improvements in performance across all three procedural learning tasks. It is important to note that no significant Serostatus x Trial Block interactions were observed on any task. Thus, the individuals in the HIV+ group tended to perform worse than those in the HIV- group across all trial blocks of procedural learning tasks with motor demands, but showed no differences in their rate of improvement across all tasks. These findings are consistent with HIV--associated deficits in complex motor skills, but not in procedural learning.

Entities:  

Mesh:

Year:  2008        PMID: 18999351      PMCID: PMC2630709          DOI: 10.1037/a0013404

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  68 in total

1.  Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input.

Authors:  Thomas W Weickert; Alejandro Terrazas; Llewellyn B Bigelow; James D Malley; Thomas Hyde; Michael F Egan; Daniel R Weinberger; Terry E Goldberg
Journal:  Learn Mem       Date:  2002 Nov-Dec       Impact factor: 2.460

2.  Delayed nonmatch-to-sample performance in HIV-seropositive and HIV-seronegative polydrug abusers.

Authors:  Eileen M Martin; David L Pitrak; Niles Rains; Silvana Grbesic; Kenneth Pursell; Gerald Nunnally; Antoine Bechara
Journal:  Neuropsychology       Date:  2003-04       Impact factor: 3.295

3.  Role of the basal ganglia in category learning: how do patients with Parkinson's disease learn?

Authors:  D Shohamy; C E Myers; S Onlaor; M A Gluck
Journal:  Behav Neurosci       Date:  2004-08       Impact factor: 1.912

Review 4.  Patterns of neurodegeneration in HIV encephalitis.

Authors:  E Masliah; N Ge; C L Achim; R DeTeresa; C A Wiley
Journal:  J NeuroAIDS       Date:  1996

Review 5.  The role of the basal ganglia in habit formation.

Authors:  Henry H Yin; Barbara J Knowlton
Journal:  Nat Rev Neurosci       Date:  2006-06       Impact factor: 34.870

6.  The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications.

Authors:  Scott H Kellogg; Pauline F McHugh; Kathy Bell; James H Schluger; Rosemary P Schluger; K Steven LaForge; Ann Ho; Mary Jeanne Kreek
Journal:  Drug Alcohol Depend       Date:  2003-03-01       Impact factor: 4.492

Review 7.  Reaction time performance in adults with HIV/AIDS.

Authors:  David J Hardy; Charles H Hinkin
Journal:  J Clin Exp Neuropsychol       Date:  2002-10       Impact factor: 2.475

8.  Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity.

Authors:  Robert H Paul; Constantin T Yiannoutsos; Eric N Miller; Linda Chang; Christina M Marra; Giovanni Schifitto; Thomas Ernst; Elyse Singer; Todd Richards; G Jeffrey Jarvik; Richard Price; Dieter J Meyerhoff; Dennis Kolson; Ronald J Ellis; Gilberto Gonzalez; Robert E Lenkinski; Ronald A Cohen; Bradford A Navia
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2007       Impact factor: 2.198

9.  Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment.

Authors:  David J Moore; Eliezer Masliah; Julie D Rippeth; Raul Gonzalez; Catherine L Carey; Mariana Cherner; Ronald J Ellis; Cristian L Achim; Thomas D Marcotte; Robert K Heaton; Igor Grant
Journal:  AIDS       Date:  2006-04-04       Impact factor: 4.177

10.  Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons.

Authors:  Julie D Rippeth; Robert K Heaton; Catherine L Carey; Thomas D Marcotte; David J Moore; Raul Gonzalez; Tanya Wolfson; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2004-01       Impact factor: 2.892

View more
  16 in total

1.  Influence of procedural learning on Iowa Gambling Task performance among HIV+ individuals with history of substance dependence.

Authors:  Raul Gonzalez; Margaret Wardle; Joanna Jacobus; Jasmin Vassileva; Eileen M Martin-Thormeyer
Journal:  Arch Clin Neuropsychol       Date:  2009-11-25       Impact factor: 2.813

2.  Neurocognitive impact of substance use in HIV infection.

Authors:  Desiree A Byrd; Robert P Fellows; Susan Morgello; Donald Franklin; Robert K Heaton; Reena Deutsch; J Hampton Atkinson; David B Clifford; Ann C Collier; Christina M Marra; Benjamin Gelman; J Allen McCutchan; Nichole A Duarte; David M Simpson; Justin McArthur; Igor Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

3.  Differential effect of alcoholism and HIV infection on visuomotor procedural learning and retention.

Authors:  Rosemary Fama; Margaret J Rosenbloom; Stephanie A Sassoon; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Alcohol Clin Exp Res       Date:  2012-07-23       Impact factor: 3.455

4.  Impact of HIV and a history of marijuana dependence on procedural learning among individuals with a history of substance dependence.

Authors:  Raul Gonzalez; Randi M Schuster; Jasmin Vassileva; Eileen M Martin
Journal:  J Clin Exp Neuropsychol       Date:  2011-06-24       Impact factor: 2.475

5.  Functional interactions of HIV-infection and methamphetamine dependence during motor programming.

Authors:  Sarah L Archibald; Mark W Jacobson; Christine Fennema-Notestine; Miki Ogasawara; Steven P Woods; Scott Letendre; Igor Grant; Terry L Jernigan
Journal:  Psychiatry Res       Date:  2012-05-17       Impact factor: 3.222

6.  An investigation of the effects of antiretroviral central nervous system penetration effectiveness on procedural learning in HIV+ drug users.

Authors:  Michael J Wilson; Lindsay Martin-Engel; Jasmin Vassileva; Raul Gonzalez; Eileen M Martin
Journal:  J Clin Exp Neuropsychol       Date:  2013-10-01       Impact factor: 2.475

7.  Decision making among HIV+ drug using men who have sex with men: a preliminary report from the Chicago Multicenter AIDS Cohort Study.

Authors:  Eileen M Martin; Samantha DeHaan; Jasmin Vassileva; Raul Gonzalez; Joshua Weller; Antoine Bechara
Journal:  J Clin Exp Neuropsychol       Date:  2013-05-24       Impact factor: 2.475

Review 8.  An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research.

Authors:  Lisa R Norman; Michael Basso
Journal:  Curr Drug Abuse Rev       Date:  2015

9.  Thalamic volume deficit contributes to procedural and explicit memory impairment in HIV infection with primary alcoholism comorbidity.

Authors:  Rosemary Fama; Margaret J Rosenbloom; Stephanie A Sassoon; Torsten Rohlfing; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Brain Imaging Behav       Date:  2014-12       Impact factor: 3.978

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.